FDA Approves Zepbound for Sleep Apnea: Navigating GLP-1 Coverage Amidst Rising Costs
The landscape of sleep apnea treatment is undergoing a significant transformation with the recent U.S. Food and Drug Administration (FDA) approval of tirzepatide (Zepbound) for moderate to severe Obstructive Sleep…
